{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:04:06Z","timestamp":1777950246497,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Southwest Medical University","award":["2024ZKY082"],"award-info":[{"award-number":["2024ZKY082"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82472016"],"award-info":[{"award-number":["82472016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"major science and technology project in Gansu Province","award":["23ZDFA014"],"award-info":[{"award-number":["23ZDFA014"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04649-w","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:49:15Z","timestamp":1777877355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical value of multi-time-point 68Ga-Pentixafor PET\/CT imaging in the subtype diagnosis of primary aldosteronism"],"prefix":"10.1007","volume":"91","author":[{"given":"Tingting","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"4649_CR1","doi-asserted-by":"publisher","first-page":"e2255609","DOI":"10.1001\/jamanetworkopen.2022.55609","volume":"6","author":"J Hu","year":"2023","unstructured":"J. Hu, T. Xu, H. Shen et al., Accuracy of gallium-68 pentixafor positron emission tomography-computed tomography for subtyping diagnosis of primary aldosteronism. JAMA Netw. Open. 6, e2255609 (2023)","journal-title":"JAMA Netw. Open."},{"key":"4649_CR2","doi-asserted-by":"publisher","first-page":"1291775","DOI":"10.3389\/fendo.2024.1291775","volume":"15","author":"X Yin","year":"2024","unstructured":"X. Yin, K. Ai, J. Luo et al., A comparison of the performance of 68Ga-Pentixafor PET\/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism. Front. Endocrinol. (Lausanne). 15, 1291775 (2024)","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4649_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11307-024-01976-0","volume":"27","author":"T Yi","year":"2025","unstructured":"T. Yi, D. Lu, Y. Cui et al., 68Ga-pentixafor PET\/CT is a supplementary method for primary aldosteronism subtyping compared with adrenal vein sampling. Mol. Imaging Biol. 27, 142\u2013150 (2025)","journal-title":"Mol. Imaging Biol."},{"key":"4649_CR4","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.2967\/jnumed.124.268169","volume":"65","author":"JS Enke","year":"2024","unstructured":"J.S. Enke, K. Ritzel, E. Asbach et al., C-X-C motif chemokine receptor 4-directed scintigraphy using [99mTc]Tc-Pentixatec in primary aldosteronism: A proof-of-concept study. J. Nucl. Med. 65, 1640\u20131644 (2024)","journal-title":"J. Nucl. Med."},{"key":"4649_CR5","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00330-022-09058-x","volume":"33","author":"Y Gao","year":"2023","unstructured":"Y. Gao, J. Ding, Y. Cui et al., Functional nodules in primary aldosteronism: identification of CXCR4 expression with 68Ga-pentixafor PET\/CT. Eur. Radiol. 33, 996\u20131003 (2023)","journal-title":"Eur. Radiol."},{"key":"4649_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3389\/fendo.2019.00810","volume":"10","author":"Y Cui","year":"2019","unstructured":"Y. Cui, Y. Zhang, J. Ding et al., A rare aldosterone-producing adenoma detected by 68Ga-pentixafor PET-CT: A case report and literature review. Front. Endocrinol. (Lausanne). 10, 810 (2019)","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"4649_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13550-024-01125-2","volume":"14","author":"R Zuo","year":"2024","unstructured":"R. Zuo, S. Liu, W. Li, Z. Xia, L. Xu, H. Pang, Clinical value of 68Ga-pentixafor PET\/CT in patients with primary aldosteronism and bilateral lesions: preliminary results of a single-centre study. EJNMMI Res. 14, 61 (2024)","journal-title":"EJNMMI Res."},{"key":"4649_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12020-024-04024-7","volume":"87","author":"R Zuo","year":"2025","unstructured":"R. Zuo, S. Liu, X. Ren et al., Typing diagnostic value of 68Ga-pentixafor PET\/CT for patients with primary aldosteronism and unilateral nodules. Endocrine. 87, 314\u2013324 (2025)","journal-title":"Endocrine"},{"key":"4649_CR9","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2967\/jnumed.123.266061","volume":"65","author":"J Ding","year":"2024","unstructured":"J. Ding, X. Li, S. Liu et al., Clinical value of 68Ga-pentixafor PET\/CT in subtype diagnosis of primary aldosteronism patients with adrenal micronodules. J. Nucl. Med. 65, 117\u2013124 (2024)","journal-title":"J. Nucl. Med."},{"key":"4649_CR10","doi-asserted-by":"publisher","first-page":"e2583","DOI":"10.1210\/clinem\/dgae747","volume":"110","author":"X Zhang","year":"2025","unstructured":"X. Zhang, Y. Song, Y. Jing et al., Comparison of different diagnostic criteria of 68Ga-pentixafor PET\/CT for the classification of primary aldosteronism. J. Clin. Endocrinol. Metab. 110, e2583\u2013e2590 (2025)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4649_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/clinem\/dgad421","volume":"109","author":"Y Zheng","year":"2023","unstructured":"Y. Zheng, T. Long, N. Peng et al., The value of targeting CXCR4 with 68Ga-pentixafor PET\/CT for subtyping primary aldosteronism. J. Clin. Endocrinol. Metab. 109, 171\u2013182 (2023)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4649_CR12","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2967\/jnumed.121.261964","volume":"63","author":"J Ding","year":"2022","unstructured":"J. Ding, A. Tong, Y. Zhang et al., Functional characterization of adrenocortical masses in nononcologic patients using 68Ga-pentixafor. J. Nucl. Med. 63, 368\u2013375 (2022)","journal-title":"J. Nucl. Med."},{"key":"4649_CR13","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"B. Heinze, C.T. Fuss, P. Mulatero et al., Targeting CXCR4 (CXC chemokine receptor Type 4) for molecular imaging of aldosterone-producing adenoma. Hypertension. 71, 317\u2013325 (2018)","journal-title":"Hypertension"},{"key":"4649_CR14","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","volume":"47","author":"J Ding","year":"2020","unstructured":"J. Ding, Y. Zhang, J. Wen et al., Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism. Eur. J. Nucl. Med. Mol. Imaging. 47, 2656\u20132665 (2020)","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4649_CR15","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/er.2018-00139","volume":"39","author":"A Vaidya","year":"2018","unstructured":"A. Vaidya, P. Mulatero, R. Baudrand, G.K. Adler, The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr. Rev. 39, 1057\u20131088 (2018)","journal-title":"Endocr. Rev."},{"key":"4649_CR16","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"J.W. Funder, R.M. Carey, F. Mantero et al., The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 1889\u20131916 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4649_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","volume":"33","author":"O Mete","year":"2022","unstructured":"O. Mete, L.A. Erickson, C.C. Juhlin et al., Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr. Pathol. 33, 155\u2013196 (2022)","journal-title":"Endocr. Pathol."},{"key":"4649_CR18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1161\/CIRCULATIONAHA.118.033597","volume":"138","author":"JB Byrd","year":"2018","unstructured":"J.B. Byrd, A.F. Turcu, R.J. Auchus, Primary aldosteronism: practical approach to diagnosis and management. Circulation. 138, 823\u2013835 (2018)","journal-title":"Circulation"},{"key":"4649_CR19","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1007\/s12020-024-03865-6","volume":"85","author":"X Wei","year":"2024","unstructured":"X. Wei, F. Wu, H. Dong et al., 68Ga-pentixafor PET\/CT in the localization diagnosis of primary aldosteronism concurrent subclinical cushing\u2019s syndrsome: two case reports. Endocrine. 85, 1398\u20131406 (2024)","journal-title":"Endocrine"},{"key":"4649_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"G.P. Rossi, R.J. Auchus, M. Brown et al., An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 63, 151\u2013160 (2014)","journal-title":"Hypertension"},{"key":"4649_CR21","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"T.A. Williams, J.W.M. Lenders, P. Mulatero et al., Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 5, 689\u2013699 (2017)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4649_CR22","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s00259-016-3419-0","volume":"43","author":"A Afshar-Oromieh","year":"2016","unstructured":"A. Afshar-Oromieh, H. Hetzheim, W. K\u00fcbler et al., Radiation dosimetry of 68Ga-PSMA-11 (HBED-CC) and preliminary evaluation of optimal imaging timing. Eur. J. Nucl. Med. Mol. Imaging. 43, 1611\u20131620 (2016)","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4649_CR23","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.2967\/jnumed.115.161299","volume":"56","author":"A Afshar-Oromieh","year":"2015","unstructured":"A. Afshar-Oromieh, H. Hetzheim, C. Kratochwil et al., The theranostic PSMA ligand PSMA-617 in the diagnosis of prostate cancer by PET\/CT: biodistribution in humans, radiation dosimetry, and first evaluation of tumor lesions. J. Nucl. Med. 56, 1697\u20131705 (2015)","journal-title":"J. Nucl. Med."},{"key":"4649_CR24","doi-asserted-by":"publisher","first-page":"410","DOI":"10.2967\/jnumed.114.151647","volume":"56","author":"K Herrmann","year":"2015","unstructured":"K. Herrmann, C. Lapa, H.-J. Wester et al., Biodistribution and radiation dosimetry for the chemokine receptor CXCR4-targeting probe 68Ga-pentixafor. J. Nucl. Med. 56, 410\u2013416 (2015)","journal-title":"J. Nucl. Med."},{"key":"4649_CR25","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2967\/jnumed.112.114165","volume":"54","author":"RC Walker","year":"2013","unstructured":"R.C. Walker, G.T. Smith, E. Liu, B. Moore, J. Clanton, M. Stabin, Measured human dosimetry of 68Ga-DOTATATE. J. Nucl. Med. 54, 855\u2013860 (2013)","journal-title":"J. Nucl. Med."},{"key":"4649_CR26","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.2967\/jnumed.124.268147","volume":"65","author":"AJ Poot","year":"2024","unstructured":"A.J. Poot, C. Lapa, W.A. Weber et al., [68Ga]Ga-RAYZ-8009: A Glypican-3-Targeted diagnostic radiopharmaceutical for hepatocellular carcinoma molecular imaging-A first-in-human case series. J. Nucl. Med. 65, 1597\u20131603 (2024)","journal-title":"J. Nucl. Med."},{"key":"4649_CR27","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2967\/jnumed.122.263884","volume":"63","author":"S Suilamo","year":"2022","unstructured":"S. Suilamo, X.-G. Li, P. Lankinen et al., 68Ga-citrate PET of healthy men: whole-body biodistribution kinetics and radiation dose estimates. J. Nucl. Med. 63, 1598\u20131603 (2022)","journal-title":"J. Nucl. Med."},{"key":"4649_CR28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.2967\/jnumed.123.267281","volume":"65","author":"B Kline","year":"2024","unstructured":"B. Kline, S. Yadav, Y. Seo et al., 68Ga-FAP-2286 PET of solid tumors: biodistribution, dosimetry, and comparison with 18F-FDG. J. Nucl. Med. 65, 938\u2013943 (2024)","journal-title":"J. Nucl. Med."},{"key":"4649_CR29","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2967\/jnumed.119.236786","volume":"61","author":"C Meyer","year":"2020","unstructured":"C. Meyer, M. Dahlbom, T. Lindner et al., Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients. J. Nucl. Med. 61, 1171\u20131177 (2020)","journal-title":"J. Nucl. Med."},{"key":"4649_CR30","doi-asserted-by":"publisher","first-page":"e038489","DOI":"10.1136\/bmjopen-2020-038489","volume":"10","author":"Y Zhou","year":"2020","unstructured":"Y. Zhou, D. Wang, L. Jiang et al., Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis. BMJ Open. 10, e038489 (2020)","journal-title":"BMJ Open."},{"key":"4649_CR31","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1097\/HJH.0000000000002948","volume":"39","author":"KM Chen","year":"2021","unstructured":"K.M. Chen, Y.L. Chang, T.H. Wu et al., Aldosterone-producing adenoma-harbouring KCNJ5 mutations is associated with lower prevalence of metabolic disorders and abdominal obesity. J. Hypertens. 39, 2353\u20132360 (2021)","journal-title":"J. Hypertens."},{"key":"4649_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11906-019-0985-0","volume":"21","author":"F Holler","year":"2019","unstructured":"F. Holler, D.A. Heinrich, C. Adolf et al., Steroid profiling and immunohistochemistry for subtyping and outcome prediction in primary aldosteronism-a review. Curr. Hypertens. Rep. 21, 77 (2019)","journal-title":"Curr. Hypertens. Rep."},{"key":"4649_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","volume":"106","author":"TA Williams","year":"2021","unstructured":"T.A. Williams, C.E. Gomez-Sanchez, W.E. Rainey et al., International histopathology consensus for unilateral primary aldosteronism. J. Clin. Endocrinol. Metab. 106, 42\u201354 (2021)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04649-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04649-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04649-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:49:16Z","timestamp":1777877356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04649-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4649"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04649-w","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"3 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the\n                      Ethics Committee of\n                      Affiliated Hospital of Southwest Medical University (AHSWMU-2020187).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Fig.\u00a0\n                      \n                      and supplementary Fig.\u00a0\n                      \n                      \u2013\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"179"}}